ResearcherDublin City UniversityActive in the last 2 years
Shannon R. Nelson
Matched on ORCID iD 0000-0003-3014-6679; OpenAlex author ID A5064577386, A5109698637. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2020: 3 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 5
- Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity. Co-author DOI 10.1038/s41420-025-02382-3↗
- Serendipity meets synergism: differential enantiomer activities of a RAD51-BRCA2 disruptor towards a more robust synthetic lethality in pancreatic cancer Co-author DOI 10.21203/rs.3.rs-4031427/v1↗
- Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development. Co-author DOI 10.1038/s41598-020-59368-7↗
- Genomic Profiling and Functional Analysis of let-7c miRNA-mRNA Interactions Identify SOX13 to Be Involved in Invasion and Progression of Pancreatic Cancer. Co-author DOI 10.1155/2020/2951921↗
- Genetic Alterations Featuring Biological Models to Tailor Clinical Management of Pancreatic Cancer Patients. Co-author DOI 10.3390/cancers12051233↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Naomi Walsh · 5 shared papers, 2020–2025 · strength 0.80
- Paper Genetic Alterations Featuring Biological Models to Tailor Clinical Management of Pancreatic Cancer Patients. DOI 10.3390/cancers12051233↗
- Paper Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential ac… DOI 10.1038/s41420-025-02382-3↗
- Paper Serendipity meets synergism: differential enantiomer activities of a RAD51-BRCA2 disruptor towards a more robust synthe… DOI 10.21203/rs.3.rs-4031427/v1↗
- Greta Bagnolini · 2 shared papers, 2024–2025 · strength 0.35
- Paper Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential ac… DOI 10.1038/s41420-025-02382-3↗
- Paper Serendipity meets synergism: differential enantiomer activities of a RAD51-BRCA2 disruptor towards a more robust synthe… DOI 10.21203/rs.3.rs-4031427/v1↗
- Marinella Roberti · 2 shared papers, 2024–2025 · strength 0.35
- Paper Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential ac… DOI 10.1038/s41420-025-02382-3↗
- Paper Serendipity meets synergism: differential enantiomer activities of a RAD51-BRCA2 disruptor towards a more robust synthe… DOI 10.21203/rs.3.rs-4031427/v1↗
- Stefania Girotto · 2 shared papers, 2024–2025 · strength 0.35
- Paper Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential ac… DOI 10.1038/s41420-025-02382-3↗
- Paper Serendipity meets synergism: differential enantiomer activities of a RAD51-BRCA2 disruptor towards a more robust synthe… DOI 10.21203/rs.3.rs-4031427/v1↗
- Andrea Cavalli · 2 shared papers, 2024–2025 · strength 0.35
- Paper Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential ac… DOI 10.1038/s41420-025-02382-3↗
- Paper Serendipity meets synergism: differential enantiomer activities of a RAD51-BRCA2 disruptor towards a more robust synthe… DOI 10.21203/rs.3.rs-4031427/v1↗
- Samuel Harry Myers · 2 shared papers, 2024–2025 · strength 0.35
- Paper Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential ac… DOI 10.1038/s41420-025-02382-3↗
- Paper Serendipity meets synergism: differential enantiomer activities of a RAD51-BRCA2 disruptor towards a more robust synthe… DOI 10.21203/rs.3.rs-4031427/v1↗
- Mirco Masi · 2 shared papers, 2024–2025 · strength 0.35
- Paper Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential ac… DOI 10.1038/s41420-025-02382-3↗
- Paper Serendipity meets synergism: differential enantiomer activities of a RAD51-BRCA2 disruptor towards a more robust synthe… DOI 10.21203/rs.3.rs-4031427/v1↗
- Sandra Roche · 2 shared papers, 2020 · strength 0.21
- Paper Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line org… DOI 10.1038/s41598-020-59368-7↗
- Paper Genomic Profiling and Functional Analysis of let-7c miRNA-mRNA Interactions Identify SOX13 to Be Involved in Invasion a… DOI 10.1155/2020/2951921↗
- Fiona O’Neill · 2 shared papers, 2020 · strength 0.21
- Paper Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line org… DOI 10.1038/s41598-020-59368-7↗
- Paper Genomic Profiling and Functional Analysis of let-7c miRNA-mRNA Interactions Identify SOX13 to Be Involved in Invasion a… DOI 10.1155/2020/2951921↗
- Annemarie Larkin · 2 shared papers, 2020 · strength 0.21
- Paper Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line org… DOI 10.1038/s41598-020-59368-7↗
- Paper Genomic Profiling and Functional Analysis of let-7c miRNA-mRNA Interactions Identify SOX13 to Be Involved in Invasion a… DOI 10.1155/2020/2951921↗
- Giovanni Ferrandi · 1 shared paper, 2025 · strength 0.18
- Martin M. Clynes · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.